NASDAQ: GILDGilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?
Insider buying vs selling
Have Gilead Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew D. Dickinson | Chief Financial Officer | 2026-06-15 | 3,000 | $125.40 | $376.20kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-06-15 | 1,480 | $123.42 | $182.66kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-06-15 | 1,070 | $124.00 | $132.68kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-06-15 | 450 | $125.40 | $56.43kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-06-10 | 1,341 | $121.48 | $162.90kSell |
| Wettan Keeley M. Cain | EVP Gen Counsel Legal Comp | 2026-06-10 | 283 | $121.48 | $34.38kSell |
| Andrew D. Dickinson | Chief Financial Officer | 2026-06-10 | 1,341 | $121.48 | $162.90kSell |
| Daniel Patrick Oday | Chairman CEO | 2026-06-10 | 4,213 | $121.48 | $511.80kSell |
| Dietmar Berger | Chief Medical Officer | 2026-06-10 | 263 | $121.48 | $31.95kSell |
| Daniel Patrick Oday | Chairman CEO | 2026-06-01 | 1,038 | $132.97 | $138.02kSell |
GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GILD insiders and whales buy or sell their stock.
GILD Shareholders
What type of owners hold Gilead Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 9.59% | 119,010,973 | $15.04B | Institution |
| Vanguard Capital Management LLC | 6.50% | 80,654,776 | $10.19B | Institution |
| Fmr LLC | 5.79% | 71,906,290 | $9.08B | Institution |
| State Street Corp | 4.82% | 59,858,585 | $7.56B | Institution |
| Capital World Investors | 3.33% | 41,283,933 | $5.22B | Institution |
| Vanguard Portfolio Management LLC | 2.83% | 35,129,465 | $4.44B | Institution |
| Jpmorgan Chase Co | 2.74% | 33,992,410 | $4.29B | Institution |
| Geode Capital Management LLC | 2.39% | 29,726,052 | $3.76B | Institution |
| Capital Research Global Investors | 2.18% | 27,127,533 | $3.43B | Institution |
| Price T Rowe Associates Inc | 2.11% | 26,248,108 | $3.32B | Institution |
GILD vs General Drug Manufacturer Stocks
Gilead Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.